SAFETY AND EFFICACY OF UPADACITINIB FOR PEDIATRIC PATIENTS WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS: AN INTERIM ANALYSIS OF AN OPEN-LABEL, PHASE 1 TRIAL

被引：4

作者：

Brunner, H. ^{[1
]}

Horneff, G. ^{[2
,3
]}

Foeldvari, I. ^{[4
]}

Anton, J. ^{[5
]}

Mohamed, M. E. ^{[6
]}

Qian, Y. ^{[6
]}

Unnebrink, K. ^{[7
]}

Hao, S. ^{[6
]}

Camp, H. ^{[6
]}

Khan, N. ^{[6
]}

Shmagel, A. ^{[6
]}

机构：

[1] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Rheumatol, Cincinnati, OH USA

[2] Asklepios Clin Sankt Augustin, Gen Pediat, St Augustin, Germany

[3] Univ Hosp Cologne, Paediat & Adolescents Med, Cologne, Germany

[4] Klinikum Eilbek, Hamburger Zentrum Kinder & Jugendrheumatol, Hamburg, Germany

[5] Univ Barcelona, Hosp Sant Joan Deu, Pediat Rheumatol, Barcelona, Spain

[6] AbbVie, Rheumatol, N Chicago, IL USA

[7] AbbVie Deutschland GmbH & Co KG, Rheumatol, Ludwigshafen, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

Clinical Trials; Safety; Outcome measures;

D O I：

10.1136/annrheumdis-2023-eular.3987

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：108 / 109

页数：2

共 50 条

[31] Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis: Results from an Open-Label Long-Term Followup Study
Brunner, Hermine L.
Ruperto, Nicolino
Quartier, Pierre
Constantin, Tamas
Alexeeva, Ekaterina
Schneider, Rayfel
Kone-Paut, Isabelle
Schikler, Kenneth
Marzan, Katherine
Wulffraat, Nico
Padeh, Shai
Chasnyk, Vyacheslav
Wouters, Carine
Kuemmerle-Deschner, Jasmin B.
Kallinich, Tilmann
Lauwerys, Bernard
Haddad, Elie
Nasonov, Evgeny L.
Trachana, Maria
Vougiouka, Olga
Leon, Karolynn
Speziale, Antonio
Lheritier, Karine
Vritzali, Eleni
Lovell, Daniel J.
Martini, Alberto
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[32] Efficacy and safety of etanercept biosimilar rhTNFR-Fc in Chinese patients with juvenile idiopathic arthritis: An open-label multicenter observational study
Xu, Xuefeng
Liu, Xiaohui
Zheng, Wenjie
Xiao, Jihong
Li, Xiaozhong
Wu, Ling
Zou, Lixia
Ouyang, Qian
Shangguan, Yaoyao
Lin, Kezhao
Dai, Xiaomei
Chen, Yuanling
Xu, Yiping
Wu, Jianqiang
Lu, Meiping
FRONTIERS IN PEDIATRICS, 2022, 10
[33] Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study
Brunner, Hermine I.
Akikusa, Jonathan D.
Al-Abadi, Eslam
Bohnsack, John F.
Boteanu, Alina Lucica
Chedeville, Gaelle
Cuttica, Ruben
De La Pena, Wendy
Jung, Lawrence
Kasapcopur, Ozgur
Kobusinska, Katarzyna
Schulert, Grant S.
Neiva, Claudia
Rivas-Chacon, Rafael
Rizo Rodriguez, Juan Cruz
Vazquez-Del Mercado, Monica
Wagner-Weiner, Linda
Weiss, Jennifer E.
Wouters, Carine
Posner, Holly
Wouters, Ann
Chang, Cheng
White, Claire
Kanik, Keith
Liu, Shixue
Martini, Alberto
Lovell, Daniel J.
Ruperto, Nicolino
ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (11) : 1561 - 1571
[34] Efficacy and safety of treatment with Infliximab in patients with early Oligo- and Polyarticular Juvenile Idiopathic Arthritis
Mitenko, Elena
Alexeeva, Ekaterina
Valieva, Sanya
Bzarova, Tatyana
Sleptsova, Tatyana
Isaeva, Kseniya
Lisitsyn, Alexander
Denisova, Rina
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 439 - 439
[35] Efficacy and Safety of Tocilizumab in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data From CHERISH
Brunner, Hermine
Ruperto, Nicolino
Zuber, Zbigniew
Cuttica, Ruben J.
Xavier, Ricardo
Calvo, Inmaculada
Rubio, Nadina
Alekseeva, Ekaterina
Chasnyk, Vyacheslav
Chavez, Jose
Horneff, Gerd
Opoka-Winiarska, Violetta
Quartier, Pierre
Spindler, Alberto
Keane, Caroline
Bharucha, Kamal N.
Wang, Jianmei
Lovell, Daniel J.
Martini, Alberto
De Benedetti, Fabrizio
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S5 - S6
[36] Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study
Iwata, Naomi
Nishimura, Kenichi
Hara, Ryoki
Imagawa, Tomoyuki
Shimizu, Masaki
Tomiita, Minako
Umebayashi, Hiroaki
Takei, Syuji
Seko, Noriko
Wakabayashi, Ryota
Yokota, Shumpei
MODERN RHEUMATOLOGY, 2023, 33 (06) : 1162 - 1170
[37] Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study
Naing, Aung
Mahipal, Amit
Javle, Milind
Wang, Judy
Bauer, Todd M.
Bajor, David L.
Elias, Anthony D.
Shields, Anthony
Davis, Elizabeth
Chawla, Sant
Safran, Howard
Powderly, John D.
D'Amato, Gina
Meyer, Christian F.
Tang, Xiongwen
Yao, Sheng
Keegan, Patricia
JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2025, 8 (01) : 71 - 81
[38] Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial
Violetta Opoka-Winiarska
Zbigniew Żuber
Ekaterina Alexeeva
Vyacheslav Chasnyk
Irina Nikishina
Grażyna Dębowska
Elżbieta Smolewska
Clinical Rheumatology, 2018, 37 : 1807 - 1816
[39] Efficacy and safety of tofacitinib in the treatment of refractory cases of polyarticular course juvenile idiopathic arthritis: A study from Bangladesh
Rahman, Mohammad Masudur
Laila, Kamrul
Rahman, Shahana Akhter
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (06) : 678 - 684
[40] Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial
Opoka-Winiarska, Violetta
Zuber, Zbigniew
Alexeeva, Ekaterina
Chasnyk, Vyacheslav
Nikishina, Irina
Debowska, Grazyna
Smolewska, Elzbieta
CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1807 - 1816

← 1 2 3 4 5 →